(27), EGCG can improve the symptoms of arthritis in rat CIA model, which may be achieved by reducing the level of pro-inflammatory cytokines (IL-17 and TNF-α), regulating the transcription factor Nrf2 and the balance between the induced inflammation and oxidation-oxidation resistance. Here, NFE2L2 is linked to arthritic joint disease.